CAI logo

Caris Life Sciences, Inc. (CAI)

Profile

Full Name

Caris Life Sciences, Inc.

Ticker

NASDAQ: CAI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 18, 2025

Indexes

Not included

Website

http://www.carislifesciences.com

Employees

1769

Key Details

Price

$29.50(+7.19%)

Market cap

$8.76B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$412.26M(+34.67% YoY)

Annual EPS

-$1.27(+18.22% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $29.50
    CAI price is $29.50

    30-Day Relative Volume

    0.52
    CAI 30-day relative volume is 0.52

    Price Performance

    Price Most recent change

    +7.19%
    CAI price was up +7.19% on Jul 30, 2025

    Price YTD change

    -
    CAI price ytd change is unknown

    Price 1-year change

    -
    CAI price 1-year change is unknown

    Price 3-year change

    -
    CAI price 3-year change is unknown

    Price Range

    Price All-time high

    $33.41
    CAI price is currently -11.71% below its historical high of $33.41

    Price 3-year low

    $25.40
    CAI price is currently +16.14% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.76B
    CAI market capitalization is $8.76 billion

    Market cap 3-year change

    -
    CAI market capitalization 3-year change is unknown

    Market cap All-time high

    $9.33B
    CAI market capitalization is currently -6.05% below its historical high of $9.33 billion

    Market cap sector rank

    91.84%
    CAI market capitalization is higher than 91.84% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1611.71%
    CAI shares outstanding is up +1611.71% year-on-year

    Shares Outstanding 3-Year Change

    +1611.71%
    CAI shares outstanding is up +1611.71% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.61
    CAI beta is 0.61

    200-day SMA

    $27.92
    CAI price is currently +5.65% above its 200-day simple moving average

    50-day SMA

    $27.92
    CAI price is currently +5.65% above its 50-day simple moving average

    RSI

    54.85
    CAI 14-day relative strength index is 54.85

    Volume

    0.52
    CAI 30-day relative volume is 0.52

    ATR

    $1.95
    CAI average true range is $1.95

    10-day Historical Volatility

    79.99%
    CAI 10-day historical volatility is 79.99%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $412.26M
    CAI annual revenue is $412.26 million

    Revenue Analysts estimate

    -
    CAI annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +34.67%
    CAI annual revenue is up +34.67% year-on-year

    Revenue Sector rank

    71.85%
    CAI annual revenue is higher than 71.85% of companies in Healthcare sector

    EPS

    EPS

    -$1.27
    CAI annual earnings per share is -$1.27

    EPS Analysts estimate

    -
    CAI annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +18.22%
    CAI annual earnings per share is up +18.22% year-on-year

    EPS Sector rank

    49.71%
    CAI annual earnings per share is higher than 49.71% of companies in Healthcare sector

    Profit

    Gross profit

    $178.78M
    CAI annual gross profit is $178.78 million

    Gross margin

    43.37%
    CAI annual gross profit margin is 43.37%

    Operating profit

    -$257.12M
    CAI annual operating income is -$257.12 million

    Operating margin

    -62.37%
    CAI annual operating profit margin is -62.37%

    Net income

    -$281.89M
    CAI annual net profit is -$281.89 million

    Net margin

    -68.38%
    CAI annual net profit margin is -68.38%

    Expenses

    Total expenses

    $669.38M
    CAI annual total expenses is $669.38 million

    Operating expenses

    $435.90M
    CAI annual total operating expenses is $435.90 million

    Cost of goods sold

    $233.48M
    CAI annual cost of goods sold is $233.48 million

    Selling, general & administrative expenses

    $321.86M
    CAI annual SGA is $321.86 million

    Depreciation and amortization

    $48.91M
    CAI annual depreciation & amortization is $48.91 million

    Interest expense

    $50.02M
    CAI annual interest expense is $50.02 million

    Income tax

    $0.00
    CAI annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$231.87M
    CAI annual earnings before interest & taxes is -$231.87 million

    EBITDA

    -$182.95M
    CAI annual EBITDA is -$182.95 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $343.73M
    CAI annual total assets is $343.73 million

    Non current assets

    $128.00M
    CAI annual long term assets is $128.00 million

    Current assets

    $215.73M
    CAI annual total current assets is $215.73 million

    Cash and cash equivalents

    $63.95M
    CAI annual cash & cash equivalents is $63.95 million

    Accounts receivable

    $83.64M
    CAI annual accounts receivable is $83.64 million

    Inventory

    $39.57M
    CAI annual inventory is $39.57 million

    Liabilities

    Total liabilities

    $2.84B
    CAI annual total liabilities is $2.84 billion

    Long term liabilities

    $2.68B
    CAI annual total long term liabilities is $2.68 billion

    Current liabilities

    $165.42M
    CAI annual total current liabilities is $165.42 million

    Accounts payable

    $27.79M
    CAI annual accounts payable is $27.79 million

    Debt

    Total debt

    $424.26M
    CAI annual total debt is $424.26 million

    Total debt 1-year change

    +95.41%
    CAI annual total debt is up +95.41% year-on-year

    Long term debt

    $358.09M
    CAI annual long term debt is $358.09 million

    Short term debt

    $66.17M
    CAI annual short term debt is $66.17 million

    Equity & Capital

    Shareholders equity

    -$2.50B
    CAI annual stockholders equity is -$2.50 billion

    Book value

    -$2.50B
    CAI annual book value is -$2.50 billion

    Retained earnings

    -$2.47B
    CAI annual retained earnings is -$2.47 billion

    Working capital

    $50.31M
    CAI annual working capital is $50.31 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$245.20M
    CAI annual cash flow from operations is -$245.20 million

    Cash from operations 1-year change

    +11.19%
    CAI annual cash flow from operations is up +11.19% year-on-year

    Cash from investing

    $52.93M
    CAI annual cash flow from investing activities is $52.93 million

    Cash from investing 1-year change

    -75.35%
    CAI annual cash flow from investing activities is down -75.35% year-on-year

    Cash from financing

    $200.29M
    CAI annual cash flow from financing activities is $200.29 million

    Cash from financing 1-year change

    +1876.83%
    CAI annual cash flow from financing activities is up +1876.83% year-on-year

    CAPEX

    CAPEX

    $8.44M
    CAI annual capital expenditures is $8.44 million

    CAPEX 1-year change

    -62.17%
    CAI annual capital expenditures is down -62.17% year-on-year

    Free Cash Flow

    Free cash flow

    -$253.64M
    CAI annual free cash flow is -$253.64 million

    Free cash flow 1-year change

    +15%
    CAI annual free cash flow is up +15% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    43.37%
    CAI annual gross profit margin is 43.37%

    Operating margin

    -62.37%
    CAI annual operating profit margin is -62.37%

    Net margin

    -68.38%
    CAI annual net profit margin is -68.38%

    ROA & ROE

    ROA

    -74.51%
    CAI annual return on assets is -74.51%

    ROE

    11.28%
    CAI annual return on equity is 11.28%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CAI price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CAI price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -3.37
    CAI price to book ratio is -3.37

    PB ratio Sector rank

    6.2%
    CAI price to book ratio is higher than 6.2% of companies in Healthcare sector

    PS Ratio

    PS ratio

    72.49
    CAI price to sales ratio is 72.49

    PS ratio Sector rank

    92.54%
    CAI price to sales ratio is higher than 92.54% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $9.15B
    CAI enterprise value is $9.15 billion

    Enterprise value Sector rank

    91.15%
    CAI enterprise value is higher than 91.15% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -110.61
    CAI EV/EBITDA is -110.61

    EV/EBITDA Sector rank

    1.94%
    CAI EV/EBITDA is higher than 1.94% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.30
    CAI annual current ratio is 1.30

    Quick ratio

    1.06
    CAI annual quick ratio is 1.06

    Leverage

    Debt to equity

    -0.15
    CAI annual debt to equity ratio is -0.15

    Interest coverage ratio

    -4.63
    CAI annual interest coverage ratio is -4.63

    Risk & Stability

    Piotroski F-Score

    -
    CAI piotroski f-score value is unknown

    Altman Z-Score

    -9.07
    CAI altman z-score is -9.07

    Analyst ratings

    Recent major analysts updates

    Jul 15, 25 Evercore ISI Group
    Outperform
    Jul 14, 25 Wolfe Research
    Outperform
    Jul 14, 25 TD Cowen
    Buy
    Jul 14, 25 JP Morgan
    Overweight
    Jul 14, 25 Guggenheim
    Buy
    Jul 14, 25 Citigroup
    Buy

    Institutional Ownership

    Screeners with CAI included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Best performing stocks last month
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Caris Life Sciences, Inc.?
    • Does Caris Life Sciences, Inc. pay dividends?
    • What sector is Caris Life Sciences, Inc. in?
    • What industry is Caris Life Sciences, Inc. in?
    • What country is Caris Life Sciences, Inc. based in?
    • When did Caris Life Sciences, Inc. go public?
    • Is Caris Life Sciences, Inc. in the S&P 500?
    • Is Caris Life Sciences, Inc. in the NASDAQ 100?
    • Is Caris Life Sciences, Inc. in the Dow Jones?
    • When does Caris Life Sciences, Inc. report earnings?

    What is the ticker symbol for Caris Life Sciences, Inc.?

    The ticker symbol for Caris Life Sciences, Inc. is NASDAQ:CAI

    Does Caris Life Sciences, Inc. pay dividends?

    No, Caris Life Sciences, Inc. does not pay dividends

    What sector is Caris Life Sciences, Inc. in?

    Caris Life Sciences, Inc. is in the Healthcare sector

    What industry is Caris Life Sciences, Inc. in?

    Caris Life Sciences, Inc. is in the Biotechnology industry

    What country is Caris Life Sciences, Inc. based in?

    Caris Life Sciences, Inc. is headquartered in United States

    When did Caris Life Sciences, Inc. go public?

    Caris Life Sciences, Inc.'s initial public offering (IPO) was on June 18, 2025

    Is Caris Life Sciences, Inc. in the S&P 500?

    No, Caris Life Sciences, Inc. is not included in the S&P 500 index

    Is Caris Life Sciences, Inc. in the NASDAQ 100?

    No, Caris Life Sciences, Inc. is not included in the NASDAQ 100 index

    Is Caris Life Sciences, Inc. in the Dow Jones?

    No, Caris Life Sciences, Inc. is not included in the Dow Jones index

    When does Caris Life Sciences, Inc. report earnings?

    The next expected earnings date for Caris Life Sciences, Inc. is August 12, 2025
    On this page